Mesh : Betacoronavirus COVID-19 Coronavirus Infections / epidemiology transmission Disease Transmission, Infectious / prevention & control Eye Diseases / epidemiology Humans Pandemics Pneumonia, Viral / epidemiology transmission Practice Guidelines as Topic SARS-CoV-2 Societies, Medical

来  源:   DOI:10.1097/APO.0000000000000308   PDF(Sci-hub)   PDF(Pubmed)

Abstract:
The World Health Organization declared the Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 a \"Pandemic\" on March 11, 2020. As of June 1, 2020, Severe Acute Respiratory Syndrome Coronavirus 2 has infected >6.2 million people and caused >372,000 deaths, including many health care personnel. It is highly infectious and ophthalmologists are at a higher risk of the infection due to a number of reasons including the proximity between doctors and patients during ocular examinations, microaerosols generated by the noncontact tonometer, tears as a potential source of infection, and some COVID-19 cases present with conjunctivitis. This article describes the ocular manifestations of COVID-19 and the APAO guidelines in mitigating the risks of contracting and/or spreading COVID-19 in ophthalmic practices.
摘要:
世界卫生组织于2020年3月11日宣布由严重急性呼吸系统综合症冠状病毒2引起的2019年冠状病毒病(COVID-19)为“大流行”。截至2020年6月1日,严重急性呼吸系统综合症2型冠状病毒已感染>620万人,造成>37.2万人死亡,包括许多医护人员。它具有很高的传染性,眼科医生感染的风险更高,原因有很多,包括医生和患者在眼科检查期间的距离,非接触式眼压计产生的微气溶胶,眼泪是潜在的感染源,一些COVID-19病例伴有结膜炎。本文介绍了COVID-19的眼部表现和APAO指南在减轻眼科实践中感染和/或传播COVID-19的风险方面的作用。
公众号